A Randomized, Multicenter, Parallel Design Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients Who Are Not Adequately Controlled on Lercanidipine 10mg Monotherapy.
Phase of Trial: Phase III
Latest Information Update: 08 Jul 2015
Price : $35 *
At a glance
- Drugs Lercanidipine/valsartan (Primary) ; Lercanidipine
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors LG Life Sciences
- 08 Jul 2015 Results published in the Clinical Therapeutics.
- 01 Sep 2013 New trial record